FDA Accepts Supplement for Dr Reddy's Allopurinol ANDA071587
The FDA has accepted a supplemental application for Dr Reddy's allopurinol under ANDA071587.
Therapeutic Area
Therapeutic area intelligence for Gout with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.